ARFICUS key facts
as of Oct 2026- Developer of a generative AI-powered software as a medical device (SAMD) designed to revolutionize healthcare diagnostics and analysis.
- ARFICUS is valued at approximately $130.0M as of Oct 2026 (last reported valuation).
- It has raised $52.5M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Vertex Ventures Israel, Action For India, Drishti CPS Foundation, IAC, International Accelerator — 15 tracked in total.
- Status: Privately Held (backing).
ARFICUS's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch ARFICUS: the Monday email on marks, rounds and moves
ARFICUS funding rounds
No funding rounds for ARFICUS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs ARFICUS
15+ARFICUS valuation
ARFICUS's last reported valuation was $130 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
ARFICUS investors
15 investors are on record for ARFICUS, including Vertex Ventures Israel, Action For India, Drishti CPS Foundation and IAC.
About ARFICUS
Developer of a generative AI-powered software as a medical device (SAMD) designed to revolutionize healthcare diagnostics and analysis. The platform, "MEDHINI," offers rapid and accurate genomics-based multimodal solutions for diagnostics, antimicrobial resistance, virtual clinical trials, climate change impact on human health, and insure-tech underwriting across pulmonology, neurology, nephrology, cardiology, and oncology, enabling affordable, technology-driven healthcare accessibility with a focus on social impact.
- Sector
- Healthcare
- HQ
- Jaipur, India
- Founded
- 2019
- Employees
- 186
- Website
- arficus.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.